| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 519.2K | $12.39M | - | |
| CFO | 226.6K | $5.41M | - | |
| Other | 167.0K | $3.99M | - | |
| Other | 133.2K | $3.18M | - | |
| Other | 108.9K | $2.60M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 9, 2019 | Paula Soteropoulos75 | Director | Sell | 11,582 | $64.96 | $752,349.98 | -58.1% | |
| Nov 20, 2019 | Matthew C Kapusta64 | CEO, CFO, Managing Director | Sell | 8,000 | $53.74 | $429,951.00 | -2.1% | |
| Nov 15, 2019 | Alexander Edward Kuta III81 | Executive VP, Operations | Sale+OE | 4,000 | $52.08 | $208,310.00 | -8.8% | |
| Oct 23, 2019 | Matthew C Kapusta64 | CEO, CFO, Managing Director | Sell | 8,000 | $43.22 | $345,780.64 | -2.1% | |
| Oct 15, 2019 | Alexander Edward Kuta III81 | Executive VP, Operations | Sale+OE | 4,000 | $42.35 | $169,400.00 | -8.8% | |
| Sep 19, 2019 | Robert Gut62 | Chief Medical Officer | Sell | 4,769 | $47.16 | $224,906.04 | -11.9% | |
| Sep 18, 2019 | Matthew C Kapusta64 | CEO, CFO, Managing Director | Sell | 8,000 | $47.31 | $378,485.58 | -2.0% | |
| Sep 16, 2019 | Alexander Edward Kuta III81 | Executive VP, Operations | Sale+OE | 4,000 | $47.26 | $189,040.00 | -13.1% | |
| Aug 21, 2019 | Matthew C Kapusta64 | CEO, CFO, Managing Director | Sell | 8,000 | $56.48 | $451,840.00 | -2.0% | |
| Aug 1, 2019 | Philip Astley-Sparke47 | Director | Sell | 6,460 | $60.12 | $388,344.00 | -48.7% |